mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
0.39 |
0.006 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.006 |